✦ LIBER ✦

The Clinical Efficacy of FOLFIRI and Bevacizumab in Combination as First-Line Therapy of Metastatic Colorectal Cancer

✍ Scribed by Erin Grothey; Edward Chu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical and Cost Effectiveness of Bevac

✍ Eui-Kyung Lee; Cedric Revil; Charles A. Ngoh; Johanna Lister; Jeong-Mi Kwon; Mee 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 460 KB

An observational study of bevacizumab co

✍ Huang, Meng-Lin; Kan, Jung-Yu; Ma, Cheng-Jen; Huang, Ching-Wen; Chen, Fang-Ming; 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 261 KB

Predictors of the efficacy of FOLFIRI pl

✍ Mitsukuni Suenaga; Satoshi Matsusaka; Masashi Ueno; Noriko Yamamoto; Eiji Shinoz 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 148 KB

A retrospective observational study on t

✍ López, R; Salgado, M; Reboredo, M; Grande, C; Méndez, J C; Jorge, M; Romero, C; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 320 KB

6048 A comparison of efficacy of first-l

✍ Ocvirk, J.; Rebersek, M.; Boc, M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Safety and efficacy of first-line bevaci

✍ Van Cutsem, E.; Rivera, F.; Berry, S.; Kretzschmar, A.; Michael, M.; DiBartolome 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 201 KB